Federal grants to Biospyder Technologies, Inc.
Biospyder Technologies, Inc. in Carlsbad, California received $6.3 million in federal grants from fiscal 2021 to 2025, across 5 awards. Its largest program was Biomedical Research and Research Training, with $2.9 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$6.3 million
- Awards5
- Awarded in FY 2025$0
- Largest award$2.6 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 3 | $1.1 million |
| FY 2022 | 0 | $0 |
| FY 2023 | 2 | $2.7 million |
| FY 2024 | 2 | $2.5 million |
| FY 2025 | 0 | $0 |
Programs that fund Biospyder Technologies, Inc.
| Program | Awards | Amount |
|---|---|---|
| Biomedical Research and Research Training | 2 | $2.9 million |
| Aging Research | 1 | $2.6 million |
| Human Genome Research | 1 | $459,302 |
| Environmental Health | 1 | $252,121 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 5 | $6.3 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Whole blood filter paper assay for alzheimers disease - summary biospyder proposes to develop and validate a classifier test for alzheimer’s disease (AD) that may also classify other dementias. Biospyder will market this as an ruo, then pursue development as a definitive in vitro diagnostic (IVD) te | Aging Research | September 20, 2023 | $2.6 million |
| Tempo-linc high throughput high sensitivity single cell gene expression profiling assay ph II - summary/abstract: single cell gene expression assays have become critical tools for identifying functional subtypes of cells, as well as changes within specific subtypes resulting from development, diseas | Biomedical Research and Research Training | June 22, 2023 | $2.5 million |
| Tempo-seq profiling of rna epitranscriptomic modifications | Human Genome Research | August 25, 2021 | $476,709 |
| Tempo-linc high throughput, high sensitivity single cell gene expression profiling assay - summary/abstract: single cell gene expression assays have become important tools to identify functional subtypes of cells, as well as changes within specific subtypes resulting from diseases or treatments. How | Biomedical Research and Research Training | April 15, 2021 | $402,266 |
| Tempo-seq assay and cell panel for assessing impact of genetic diversity on compound bioactivity and toxicity risk - summary: this phase i project will demonstrate the feasibility for assessing the impact of genetic diversity on exposure and inferences to the corresponding risk of toxicity across th | Environmental Health | December 25, 2020 | $252,121 |
Questions people ask
How much federal grant money does Biospyder Technologies, Inc. get?
$6.3 million in 5 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Biospyder Technologies, Inc. the most?
The Department of Health and Human Services, with $6.3 million in 5 awards.
What is Biospyder Technologies, Inc.'s largest federal grant?
$2.6 million under Aging Research, with its first action in the period on September 20, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Biospyder Technologies, Inc.?
Its largest are Biomedical Research and Research Training, Aging Research and Human Genome Research.
Other grant recipients in Carlsbad
- Smartville Inc
- Arima Genomics, Inc.
- Arisan Therapeutics Inc
- City of Carlsbad
- Crosslife Technologies Inc.
- Chelsea Investment Corporation
- Therini Bio, Inc.
- Seacoast Science, Inc.
Largest federal grant recipients in California · Federal grants in California